LEARN MORE
Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.
LEARN MOREClinical Trials
Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.
Follow Us on Twitter
#Medicalnet Maternal depression during and after pregnancy linked to poorer child t.co/2T7FfwDRDo
Retweeted by Marinus Pharma